Novel Labs Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NOVEL LABS INC
NOVEL LABS INC has fifty-six approved drugs.
There are three tentative approvals on NOVEL LABS INC drugs.
Summary for Novel Labs Inc
| US Patents: | 0 |
| Tradenames: | 42 |
| Ingredients: | 41 |
| NDAs: | 56 |
Drugs and US Patents for Novel Labs Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novel Labs Inc | AMLODIPINE BESYLATE AND VALSARTAN | amlodipine besylate; valsartan | TABLET;ORAL | 202829-001 | Mar 30, 2015 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Novel Labs Inc | POTASSIUM CHLORIDE | potassium chloride | CAPSULE, EXTENDED RELEASE;ORAL | 204828-002 | Aug 16, 2016 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Novel Labs Inc | MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE | sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate | TABLET;ORAL | 079247-001 | Dec 30, 2011 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
